Technical VS fundementalThe #UPC Court of Appeal confirmed the validity of Amgen's key Repatha patent (EP 797), securing its market lead against Sanofi. This massive legal victory clears the path for infringement proceedings and could potentially unlock value leading to a 50% stock increase!
@Amgen: The Repatha shield is
0.376 USD
3.63 B USD
29.52 B USD
About Amgen Inc.
Sector
Industry
CEO
Robert A. Bradway
Website
Headquarters
Thousand Oaks
Founded
1980
ISIN
ARDEUT110665
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Related stocks
Amgen’s Ascending TriangleAmgen rallied sharply last month, and some traders may see more upside in the drug maker.
The first pattern on today’s chart is the advance after earnings and revenue beat estimates on November 4. Such a move may reflect improved sentiment.
Second is the $337.38 level, AMGN’s previous record-high
AMGN - Combo bullish signs=======
Volume
=======
- Healthy
==========
Price Action
==========
- Bullish flag spotted
- Supported above $310
- Gapped up from a near 6 month ascending triangle
=================
Technical Indicators
=================
- Ichimoku
>>> price above cloud
>>> Green kumo expanding
>>> Tenken - A
AMGN on the Verge of a Major Breakout1. Technical Analysis
AMGN has formed a bullish pennant pattern after a strong upside rally. This compression typically acts as a continuation setup, suggesting that buyers are preparing for another push higher—if the major resistance gives way.
Key Resistance
• $346.7 → Major multi-year resist
AMGN: the medicine cabinet for your portfolioOn the weekly chart, Amgen (AMGN) trades at $289.56, holding above the key $272–280 support zone, aligned with the 0.705–0.79 Fibo levels. This area forms a clear buy zone, where buyers are likely to step in. The technical structure remains bullish: the uptrend is intact, with targets at $346.85, ma
AMGN | Healthcare STRONG | LONGAmgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Th
AMGN - To see a new high=======
Volume
=======
- neutral
==========
Price Action
==========
- rounding bottom recently
- Ascending triangle noticed
=================
Technical Indicators
=================
- Ichimoku
>>> price above cloud
>>> Green kumo budding
>>> Tenken - above clouds and pointing up
>>> Chiku - wi
Professional Technical Analysis of AMGN (Amgen Inc.)
Looking at the daily chart of AMGN, here’s the outlook:
📊 Short-Term Outlook (1–4 weeks)
Price Structure: The stock is testing a long-term ascending trendline (blue line). This level has repeatedly acted as strong support since early 2023.
Risk: If buyers fail to defend the trendline, a breakdow
See all ideas
US31162BP4
Amgen Inc. 5.375% 15-MAY-2043Yield to maturity
6.09%
Maturity date
May 15, 2043
AMGN.GA
Amgen Inc. 8.125% 01-APR-2097Yield to maturity
6.01%
Maturity date
Apr 1, 2097
US31162DU1
Amgen Inc. 5.75% 02-MAR-2063Yield to maturity
5.92%
Maturity date
Mar 2, 2063
US31162DG2
Amgen Inc. 4.4% 22-FEB-2062Yield to maturity
5.90%
Maturity date
Feb 22, 2062
US31162DT4
Amgen Inc. 5.65% 02-MAR-2053Yield to maturity
5.81%
Maturity date
Mar 2, 2053
US31162DK3
Amgen Inc. 4.875% 01-MAR-2053Yield to maturity
5.78%
Maturity date
Mar 1, 2053
AMGD
Amgen Inc. 4.2% 22-FEB-2052Yield to maturity
5.77%
Maturity date
Feb 22, 2052
US031162CF59
Amgen Inc. 4.663% 15-JUN-2051Yield to maturity
5.75%
Maturity date
Jun 15, 2051
AMGN5186584
Amgen Inc. 2.77% 01-SEP-2053Yield to maturity
5.71%
Maturity date
Sep 1, 2053
US31162BZ2
Amgen Inc. 4.4% 01-MAY-2045Yield to maturity
5.66%
Maturity date
May 1, 2045
AMGN4437315
Amgen Inc. 4.563% 15-JUN-2048Yield to maturity
5.63%
Maturity date
Jun 15, 2048
See all AMGDB bonds
Curated watchlists where AMGDB is featured.












